Sharmila Makhija, MD - Associate Professor
Gynecologic Oncology
Division Director, Gynecologic Oncology
Georgia Cancer Coalition Distinguished Cancer Scholar
Academic OfficeEmory University School of Medicine
Department of Gynecology and Obstetrics
1639 Pierce Drive, 4305 WMB
Atlanta, GA 30322
Phone ·
Email · drmakhija@emory.edu
Clinical Office
The Emory Clinic
Bldg A, 4th Floor
1365 Clifton Road, N.E.
Atlanta, GA 30322
Phone · 404-778-3401
EDUCATION
Medical School: University of Alabama at Birmingham
Birmingham, Alabama
Residency: Obstetrics and Gynecology
University of Louisville Hospital
Louisville, Kentucky
Fellowship: Gynecologic Oncology
Memorial Sloan-Kettering Cancer Center
New York, New York
BOARD CERTIFICATION
American Board of Obstetrics and Gynecology
PROFESSIONAL SOCIETIES and MEMBERSHIPS
Fellow of the American College of Obstetricians and Gynecologists (FACOG)
Society of Gynecologic Oncologists
American Association of Cancer Research
American Society of Clinical Oncology
American Society of Gene Therapy
International Society of Gynecologic Cancer
AIDS Malignancy Consortium
Association of Professors of Gynecology and Obstetrics
RESEARCH FOCUS AND SPECIAL INTERESTS
Cervical Cancer, HIV Prevention Trials, Chemoresistance in Ovarian Cancer, Monoclonal Antibody Therapy for Ovarian Cancer, Gene Therapy for Ovarian Cancer
REFERENCES
Rocconi R, Numnum M, Zhu A, Lu Baogen, Wang M, Rivera A, Stoff-Khalili M, Alvarez R, Curiel DT, Makhija S, Icodextrin Enhances Survival in an Intraperitoneal Ovarian Cancer Murine Model Utilizing Gene Therapy. Gynecol Oncol 2006
Li Y, Wang H, Wang Z, Makhija S, Buchsbaum D, LoBuglio A, Kimberly R, Zhou T. Inducible Resistance of Tumor Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 2-Mediated Apoptosis by Generation of a Blockade at the Death Domain Function. Cancer Res 2006 Sep; 66(17): 8520-8528
Zhu Z, Rivera A, Makhija S, Lu B, Wang W, Izumi M, Cerfolio RJ , Stoff-Khalili M, Zhou F, Takayama K, Siegal G, Curiel D. Targeting Lung Cancer using an Infectivity Enhanced CXCR4-CrAd. Lung Cancer 2006 Nov
Zhu ZB, Chen Y, Makhija S, Lu B, Wang M, Rivera AA, Yamamoto M, Wang S, Siegal GP, Curiel DT, McDonald JM. Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma. Int J Oncol. 2006 Nov;29(5):1319-29